Strategies for selecting/switching chemotherapy and supportive care treatments during COVID-19 outbreak
- PMID: 32779851
- PMCID: PMC7404874
- DOI: 10.1002/cam4.3314
Strategies for selecting/switching chemotherapy and supportive care treatments during COVID-19 outbreak
Conflict of interest statement
The authors have no conflicts of interests to declare.
References
-
- World Health Organization (WHO) . Coronavirus disease 2019 (COVID‐19) Situation Report‐. https://www.who.int/docs/default‐source/coronaviruse/situation‐reports/2.... Accessed June 3, 2020
-
- National Comprehensive Cancer Network . NCCN practice guidelines in Oncology Multiple Myeloma. Version 3.2020. https://www.nccn.org/professionals/physician_gls/pdf/myeloma.pdf. Accessed Mar 28th, 2020
-
- Cassidy J, Clarke S, Díaz‐Rubio E, et al. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first‐line therapy for metastatic colorectal cancer. J Clin Oncol. 2008;26(12):2006‐2012. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
